ARCH Venture Partners

ARCH Venture Partners

Investing in disruptive innovation

Investment Fund Manager | United Kingdom of Great Britain and Northern Irela | Access to Information

 

Overview

ARCH Venture Partners is a premier provider of seed and early stage venture capital for technology firms with a special competence in co founding and building firms from start up.Our mission is to deliver promising technologies from the earliest stages to successful commercial application from concept to commerce.With a 30 year history and $2 billion in capital under management ARCH has secured its place among the largest providers of seed and early stage capital in the U.S.

Investor Type

Legal Structure

Operating Status

Members

Investment Fund Manager Other Legal Structure Operating 1-10

Portfolio

Jun, 2016

Joint Series A Equity PRI

Just Biotherapeutics

Focused on the technology of biotherapeutics

Just is an integrated design company focused on the technology...

sector

Health Improvement
Disease Specific Prevention and Mitigation
Capacity Building

regions

United States of America

People

James N. Thomas

Jan, 2016

Joint Equity PRI

Lodo Therapeutics

Unearthing Nature's Medicines

Lodo Therapeutics Corporation is a drug discovery and development...

sector

Disease Specific Prevention and Mitigation
Capacity Building

regions

United States of America

People

David L. Pompliano

Dec, 2015

Joint Series B Equity PRI

AgBiome  

Crop Microbiome Biotech Company.

AgBiome is redefining agriculture. They are an early stage provider...

sector

Agricultural Productivity

regions

United States of America

People

Eric Ward


Investors / Funders


Team


Funds


Impact

Social Objectives:

Environmental Objectives:


Operational Impact:


Impact Reports & Metrics


Offices

Headquarters :

8755 W. Higgins Rd.
Chicago Illinois 60631
United States of America



Explore

Revision History


Quick Search



  • Global  
  • Africa  
  • Americas  
  • Asia  
  • Europe  
  • Oceania  


Incoming

Tags

COPYRIGHT 2017 IMPACTSPACE. ALL RIGHTS RESERVED.